MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

Human Molecular Genetics

Volumn 20, Issue 15, 2011, Pages 3067-3078

  Miñones Moyano, Elena ^a,b   Porta, Sílvia ^a,c   Escaramís, Georgia ^a   Rabionet, Raquel ^a   Iraola, Susana ^a   Kagerbauer, Birgit ^a   Espinosa Parrilla, Yolanda ^d   Ferrer, Isidre ^c,f   Estivill, Xavier ^a,e   Martí, Eulàlia ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d INSTITUTE OF EVOLUTIONARY BIOLOGY CSIC UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DJ 1 PROTEIN; MICRORNA; MIR 34B; MIR 34C; PARKIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ARTICLE; CELL VIABILITY; CEREBELLUM; DOPAMINERGIC NERVE CELL; FRONTAL CORTEX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; STAGING; SUBSTANTIA NIGRA;

BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; MICRORNAS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIAL MEMBRANES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 79960135400     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr210     Document Type: Article

References (62)

1. De Rijk, M.C., Launer, L.J., Berger, K., Breteler, M.M., Dartigues, J.F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C. et al. (2000) Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology, 54, S21-S23.
2. Shulman, J.M., De Jager, P.L. and Feany, M.B. (2010) Parkinson's disease: genetics and pathogenesis. Annu. Rev. Pathol., [Epub ahead of print].
3. Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A., Jansen Steur, E.N. and Braak, E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 24, 197-211.
4. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H. and Del Tredici, K. (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res., 318, 121-134.
5. Dauer, W. and Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron, 39, 889-909.
6. Jellinger, K.A. (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J. Neural. Transm., 111, 1219-1235.
7. Saito, Y., Ruberu, N.N., Sawabe, M., Arai, T., Kazama, H., Hosoi, T., Yamanouchi, H. and Murayama, S. (2004) Lewy body-related alpha-synucleinopathy in aging. J. Neuropathol. Exp. Neurol., 63, 742-749.
8. Douglas, M.R., Lewthwaite, A.J. and Nicholl, D.J. (2007) Genetics of Parkinson's disease and parkinsonism. Expert Rev. Neurother., 7, 657-666.
9. Tan, E.K. and Skipper, L.M. (2007) Pathogenic mutations in Parkinson disease. Hum. Mutat., 28, 641-653.
10. Xiromerisiou, G., Dardiotis, E., Tsimourtou, V., Kountra, P.M., Paterakis, K.N., Kapsalaki, E.Z., Fountas, K.N. and Hadjigeorgiou, G.M. (2010) Genetic basis of Parkinson's disease. Neurosurg. Focus, 28, E7.
11. Gao, F.B. (2008) Posttranscriptional control of neuronal development by miRNA networks. Trends Neurosci., 31, 20-26.
12. Schratt, G. (2009) microRNAs at the synapse. Nat. Rev. Neurosci., 10, 842-849.
13. Brodersen, P. and Voinnet, O. (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev. Mol. Cell Biol., 10, 141-148.
14. Ghildiyal, M. and Zamore, P.D. (2009) Small silencing RNAs: an expanding universe. Nat. Rev. Genet., 10, 94-108.
15. Sonntag, K.C. (2010) MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res., 1338, 48-57.
16. Kim, J., Inoue, K., Ishii, J., Vanti, W.B., Voronov, S.V., Murchison, E., Hannon, G. and Abeliovich, A. (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science, 317, 1220-1224.
17. Wang, G., van der Walt, J.M., Mayhew, G., Li, Y.J., Züchner, S., Scott, W.K., Martin, E.R. and Vance, J.M. (2008) Variation in the miRNA binding site of FGF20 confers risk for Parkinson disease by overexpression of a-synuclein. Am. J. Hum. Genet., 82, 283-289.
18. Junn, E., Lee, K.W., Jeong, B.S., Chan, T.W., Im, J.Y. and Mouradian, M.M. (2007) Repression of a-synuclein expression and toxicity by microRNA-7. Proc. Natl Acad. Sci. USA, 106, 13052-13057.
19. Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y. and Tokino, T. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res., 68, 4123-4132.
20. Presgraves, S.P., Ahmed, T., Borwege, S. and Joyce, J.N. (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox. Res., 5, 579-598.
21. Dodson, M.W. and Guo, M. (2007) Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr. Opin. Neurobiol., 17, 331-337.
22. Martinat, C., Shendelman, S., Jonason, A., Leete, T., Beal, M.F. et al. (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary Parkinsonism. PLoS Biol., 2, e327.
23. Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S.M., Takahashi, K. and Ariga, H. (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep., 5, 213-218.
24. Eacker, S.M., Dawson, T.M. and Dawson, V.L. (2009) Understanding microRNAs in neurodegeneration. Nat. Rev. Neurosci., 10, 837-841.
25. Corney, D.C., Flesken-Nikitin, A., Godwin, A.K., Wang, W. and Nikitin, A.Y. (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res., 67, 8433-8438.
26. Kumamoto, K., Spillare, E.A., Fujita, K., Horikawa, I., Yamashita, T., Appella, E., Nagashima, M., Takenoshita, S., Yokota, J. and Harris, C.C. (2008) Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res., 68, 3193-3203.
27. Mogi, M., Kondo, T., Mizuno, Y. and Nagatsu, T. (2007) p53 protein, interferon-g, and NF-kB levels are elevated in the parkinsonian brain. Neurosci. Lett., 414, 94-97.
28. da Costa, C.A. and Checler, F. (2010) Apoptosis in Parkinson's disease: is p53 the missing link between genetic and sporadic Parkinsonism? Cell Signal., [Epub ahead of print].
29. Suzuki, H., Yamamoto, E., Nojima, M., Kai, M., Yamano, H.O., Yoshikawa, K., Kimura, T., Kudo, T., Harada, E., Sugai, T. et al. (2010) Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis, 31, 2066-2073.
30. Liu, H., Liu, W., Wu, Y., Zhou, Y., Xue, R., Luo, C., Wang, L., Zhao, W., Jiang, J.D. and Liu, J. (2005) Loss of epigenetic control of synuclein-{gamma} gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res., 65, 7635-7643.
31. Zhao, W., Liu, H., Liu, W., Wu, Y., Chen, W., Jiang, B., Zhou, Y., Xue, R., Luo, C., Wang, L. et al. (2006) Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Int. J. Oncol., 28, 1081-1088.
32. Dexter, D.T., Sian, J., Rose, S., Hindmarsh, J.G., Mann, V.M., Cooper, J.M., Wells, F.R., Daniel, S.E., Lees, A.J., Schapira, A.H. et al. (1994 Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol., 35, 38-44.
33. Navarro, A., Boveris, A., Bández, M.J., Sánchez-Pino, M.J., Gómez, C., Muntané, G. and Ferrer, I. (2009) Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic. Biol. Med, 46, 1574-1580.
34. Parker, W.D.J., Parks, J.K. and Swerdlow, R.H. (2008) Complex I deficiency in Parkinson's disease frontal cortex. Brain Res., 1189, 215-218.
35. Ferrer, I. (2009) Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects. Prog. Neurobiol., 88, 89-103.
36. Muntané, G., Martínez, A. and Ferrer, I. (2008) Phosphorylation of tau and alphasynuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease and related alpha-synucleinopathies. Neuroscience, 152, 913-923.
37. Schulz-Schaeffer, W.J. (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease with dementia. Acta Neuropathol., 120, 131-143.
38. Tanji, M.F., Mimura, J., Itoh, K., Takahashi, H. and Wakabayashi, K. (2010) Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Acta Neuropathol., 120, 145-154.
39. Ni, Z., Pinto, A.D., Lang, A.E. and Chen, R. (2010) Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann. Neurol., 68, 816-824.
40. Payoux, P., Brefel-Courbon, C., Ory-Magne, F., Regragui, W. and Thalamas, C. (2010) Motor activation in multiple system atrophy and Parkinson's disease: a PET study. Neurology, 75, 1174-1180.
41. Winklhofer, K.F. and Haass, C. (2010) Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta, 1802, 29-44.
42. Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P. et al. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem., 54, 823-827.
43. Schapira, A.H. (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol., 7, 97-109.
44. Schapira, A.H., Mann, V.M., Cooper, J.M., Dexter, D., Daniel, S.E., Jenner, P., Clark, J.B. and Marsden, C.D. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem., 55, 2142-2145.
45. Kumaran, R., Vandrovcova, J., Luk, C., Sharma, S., Renton, A., Wood, N.W., Hardy, J.A., Lees, A.J. and Bandopadhyay, R. (2009) Differential DJ-1 gene expression in Parkinson's disease. Neurobiol. Dis., 36, 393-400.
46. Foulds, P., Mann, D.M., Mitchell, J.D. and Allsop, D. (2010) Parkinson disease: progress towards a molecular biomarker for Parkinson disease. Nat. Rev. Neurol., 6, 359-361.
47. Choi, J., Sullards, M.C., Olzmann, J.A., Rees, H.D., Weintraub, S.T. et al. (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem., 281, 10816-10824.
48. Dawson, T.M. and Dawson, V.L. (2010) The role of Parkin in familial and sporadic Parkinson's disease. Mov. Disord., 25, S32-S39.
49. Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B. and Pallanck, L.J. (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. USA, 100, 4078-4083.
50. Irrcher, I., Aleyasin, H., Seifert, E.L., Hewitt, S.J., Chhabra, S., Phillips, M., Lutz, A.K., Rousseaux, M.W., Bevilacqua, L., Jahani-Asl, A. et al. (2010) Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum. Mol. Genet., 19, 3734-3746.
51. Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. and Shen, J. (2004) Mitochondrial dysfuncion and oxidative damage in Parkin-deficient mice. J. Biol. Chem., 279, 18614-18622.
52. Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M., Bellen, H. and Mardon, G. (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development, 131, 2183-2194.
53. Chen, H. and Chan, D.C. (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet., 18, R169-R176.
54. Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A. and Guo, M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 441, 1162-1166.
55. Deng, H., Dodson, M.W., Huang, H. and Guo, M. (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl Acad. Sci. USA, 105, 14503-14508.
56. Poole, A.C., Thomas, R.E., Andrews, L.A., McBride, H.M., Whitworth, A.J. and Pallanck, L.J. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl Acad. Sci. USA, 105, 1638-1643.
57. Irrcher, I., Aleyasin, H., Seifert, E.L., Hewitt, S.J., Chhabra, S., Phillips, M., Lutz, A.K., Rousseaux, M.W., Bevilacqua, L., Jahani-Asl, A. et al. (2010) Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum. Mol. Genet., 19, 3734-3746.
58. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 -ΔΔCt method. Methods, 25, 402-408.
59. Steibel, J., Poletto, R., Coussens, P.M. and Rosa, G.J.M. (2009) A powerful and flexible linear mixed model framework for the analysis of relative quantification RT-PCR data. Genomics, 94, 146-152.
60. Lujambio, A., Calin, G.A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M.,Blanco, D.,Montuenga, L.M.,Rossi, S.,Nicoloso, M.S., Faller, W.J. et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci., 105, 13556-13561.
61. Lewin, J., Schmitt, A., Adorján, P., Hildmann, T. and Piepenbrock, C. (2004) Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics, 20, 3005-3012.
62. Wang, X., Dykens, J.A., Perez, E., Liu, R., Yang, S., Covey, D.F. and Simpkins, J.W. (2006) Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol., 70, 395-404.